In this five-part blog series, Alice Limonciel explores the role of metabolomics in 5P medicine. This second installment highlights how screening samples with broad metabolomics panels and leveraging data with knowledge-driven tools leads to the translation of metabolomics insights into innovative strategies for predictive medicine.

This is the first in a series of five blogs where Alice Limonciel discusses how metabolomics is set to transform medicine as we know it. The applications of omics in biomedical research are vast, and to help organize the different ways metabolomics can be used, I’ll discuss this in the context of 5P medicine.